CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (DEFICIT) (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Retained Earnings (Accumulated Deficit)
Beginning balance (in shares) at Jun. 30, 2024		2,279,948
Beginning balance at Jun. 30, 2024	$ 56,787	$ 114	$ 69,660	$ 8,584	$ (21,571)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(853)				(853)
Foreign currency translation	152			152
Stock-based compensation	335		335
Net restricted stock activity (in shares)		2,447
Net restricted stock activity	(23)		(23)
Ending balance (in shares) at Sep. 30, 2024		2,282,395
Ending balance at Sep. 30, 2024	$ 56,398	$ 114	69,972	8,736	(22,424)
Beginning balance (in shares) at Jun. 30, 2025	2,435,981	2,435,981
Beginning balance at Jun. 30, 2025	$ 185,616	$ 122	75,243	8,286	101,965
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	1,356				1,356
Foreign currency translation	(289)			(289)
Exercise of stock options (in shares)		11,000
Exercise of stock options	291		291
Stock-based compensation	297		297
Net restricted stock activity (in shares)		1,722
Net restricted stock activity	(19)		(19)
Common stock issued in connection with warrant exercise (in shares)		12,567
Common stock issued in connection with warrant exercise	$ 299	$ 1	298
Ending balance (in shares) at Sep. 30, 2025	2,461,270	2,461,270
Ending balance at Sep. 30, 2025	$ 187,551	$ 123	$ 76,110	$ 7,997	$ 103,321